ArticleCancer research and treatment2018
FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation.
Jinju Park et al.PubMed โFull text โPublisher โ
No numbers read from the abstract.
29 papers cite it
this papercites it